Trials / Completed
CompletedNCT02757404
Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity
Impact of Injection Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Medy-Tox · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity.
Detailed description
This study is "A Multicenter, Prospective, Randomized, Evaluator Blinded, Comparing Phase 4 Study to Evaluate the Impact of Injection Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ultrasonography guidance injection of Meditoxin®. | Meditoxin® will be injected to upper limb spasticity by using the ultrasonography guidance. |
| DRUG | Electrical stimulation guidance injection of Meditoxin®. | Meditoxin® will be injected to upper limb spasticity by using the electrical stimulation guidance. |
| DRUG | Manual needle placement injection of Meditoxin®. | Meditoxin® will be injected to upper limb spasticity by using the manual needle placement. |
Timeline
- Start date
- 2016-05-30
- Primary completion
- 2016-08-16
- Completion
- 2016-08-16
- First posted
- 2016-05-02
- Last updated
- 2019-03-29
Source: ClinicalTrials.gov record NCT02757404. Inclusion in this directory is not an endorsement.